Originator Organization Hemispherian ASStartup |
Active Organization Hemispherian ASStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NO | Hemispherian ASStartup | 27 Jul 2022 |